Discover 1,367 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,367
Active & Responsive
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 in Participants With Multiple Sclerosis.
for
Multiple Sclerosis
Location: Montreal
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18 - 65
Code: NCT05704361
Phase1, Recruiting
Active & Responsive
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
for
Mitral Valve Regurgitation
Location: Quebec, Portland ME, Lebanon NH, Ottawa, Boston MA, New York NY,
Sponsor: Annetine Gelijns
Sex: All
Age: 60+
Code: NCT05051033
Recruiting
Active & Responsive
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Sherbrooke, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 29 - 17
Code: NCT05714085
Phase2, Phase3, Recruiting
Active & Responsive
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Greenfield Park, Montreal, Quebec, Boston MA, Rochester NY,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Location: Montreal, Ottawa, Hackensack NJ, Hamilton, Iowa City IA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer